We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$39.7B
AUM Growth
+$3.58B
(+9.9%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
15.27%
Holding
2,330
New
168
Increased
907
Reduced
894
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$260M |
| 2 |
Entergy
ETR
|
+$254M |
| 3 |
Philip Morris
PM
|
+$217M |
| 4 |
Pfizer
PFE
|
+$184M |
| 5 |
LyondellBasell Industries
LYB
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$404M |
| 2 |
Merck
MRK
|
+$328M |
| 3 |
Gilead Sciences
GILD
|
+$142M |
| 4 |
Clorox
CLX
|
+$121M |
| 5 |
Align Technology
ALGN
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.7% |
| 2 | Technology | 13.73% |
| 3 | Financials | 11.58% |
| 4 | Consumer Staples | 9.23% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Shell
SHEL
$283B
| $6.04K | ﹤0.01% |
105
-100
| -49% | -$5.88K |
|
1902
Momentus
MNTS
$89M
| $6.01K | ﹤0.01% |
1
| – | – |
|
1903
Powell Industries
POWL
$6.32B
| $6K | ﹤0.01% |
+423
| New | +$5.86K |
|
1904
CRH
CRH
$58.7B
| $6K | ﹤0.01% |
118
-26
| -18% | -$1.23K |
|
1905
Olema Pharmaceuticals
OLMA
$872M
| $5.93K | ﹤0.01% |
1,709
-1,865
| -52% | -$7.61K |
|
|
UBA
1906
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $5.92K | ﹤0.01% |
+337
| New | +$6.04K |
|
1907
Orrstown Financial Services
ORRF
$837M
| $5.92K | ﹤0.01% |
298
+63
| +27% | +$1.43K |
|
|
VXRT
1908
DELISTED
Vaxart
VXRT
| $5.83K | ﹤0.01% |
7,705
+4,905
| +175% | +$4.55K |
|
|
FSFG
1909
DELISTED
First Savings Financial Group
FSFG
| $5.66K | ﹤0.01% |
352
-129
| -27% | -$2.44K |
|
1910
UFP Technologies
UFPT
$2.14B
| $5.58K | ﹤0.01% |
43
-1
| -2% | -$116 |
|
|
FRBK
1911
DELISTED
Republic First Bancorp Inc
FRBK
| $5.54K | ﹤0.01% |
+4,075
| New | +$7.99K |
|
1912
Forward Air
FWRD
$560M
| $5.5K | ﹤0.01% |
+51
| New | +$5.36K |
|
1913
Precision BioSciences
DTIL
$181M
| $5.38K | ﹤0.01% |
238
-3,356
| -93% | -$111K |
|
|
KZR
1914
DELISTED
Kezar Life Sciences
KZR
| $5.37K | ﹤0.01% |
+172
| New | +$9.95K |
|
1915
Curis
CRIS
$2.69M
| $5.32K | ﹤0.01% |
22
-16
| -42% | -$4.22K |
|
1916
Enliven Therapeutics
ELVN
$3.9B
| $5.32K | ﹤0.01% |
243
-17
| -7% | -$346 |
|
1917
Vroom Inc
VRM
$54.5M
| $5.2K | ﹤0.01% |
72
-37
| -34% | -$2.99K |
|
1918
Bolt Biotherapeutics
BOLT
$7.88M
| $5.2K | ﹤0.01% |
187
-14
| -7% | -$410 |
|
1919
iShares MSCI Japan Value ETF
EWJV
$788M
| $5.19K | ﹤0.01% |
202
| – | – |
|
1920
CAE Inc
CAE
$7.65B
| $5.18K | ﹤0.01% |
229
| – | – |
|
1921
Perdoceo Education
PRDO
$2.06B
| $5.16K | ﹤0.01% |
+384
| New | +$5.38K |
|
1922
Wabash National
WNC
$512M
| $5.14K | ﹤0.01% |
+209
| New | +$5.42K |
|
1923
Blackstone
BX
$95B
| $5.09K | ﹤0.01% |
58
-193
| -77% | -$17K |
|
1924
Crown Holdings
CCK
$12.2B
| $4.96K | ﹤0.01% |
60
| – | – |
|
|
TRML
1925
DELISTED
Tourmaline Bio
TRML
| $4.91K | ﹤0.01% |
261
+93
| +55% | +$1.53K |
|
Similar funds
Federated Hermes's Q1 2023 Portfolio in Review
As of Q1 2023, Federated Hermes held 2,330 positions worth $39.7B, up 9.9% from $36.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.92B of net new capital in Q1 2023, opening 168 new positions and adding to 907 existing holdings. Its largest new stake was Rogers Corp: 345,466 shares worth $56.5M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $404M trimmed.
- Federated Hermes's largest Q1 2023 buy was Rogers Corp: 345,466 shares worth $56.5M.
- Federated Hermes added most to Williams Companies in Q1 2023, an estimated $260M increase.
- Federated Hermes's biggest Q1 2023 reduction was JPMorgan Chase, cutting an estimated $404M.
- Federated Hermes fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $56.3M.
- Federated Hermes's ten largest holdings make up 15% of its $39.7B portfolio in Q1 2023.
- Federated Hermes opened 168 new positions and closed 217 in Q1 2023.
- Federated Hermes's portfolio value rose 9.9% quarter-over-quarter to $39.7B.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.